Identifying Local Field Potential Biomarkers for Obsessive-compulsive Disorder Treatment With Deep Brain Stimulation

Status: Recruiting
Location: See all (4) locations...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Obsessive-compulsive disorder (OCD) is a complex and severe mental illness characterized by multiple symptoms and is considered a leading cause of non-fatal health loss. However, nearly 20% of patients do not respond to standard pharmacological or psychological treatments. Currently, we lack objective brain-based biomarkers. To address this issue, we used a novel device for electrophysiology recording and applied deep brain stimulation (DBS) to 16 OCD patients. In this study, we aim to use long-term invasive neural signal collection and machine learning techniques to reveal the complex relationship between these signals and OCD symptoms. By applying advanced machine learning algorithms, our goal is to establish highly accurate prediction models to identify biomarkers associated with the occurrence and progression of OCD. The research will focus on the spatiotemporal features of neural signals and build personalized OCD decoding models based on individual differences through the integration and analysis of large-scale data. By delving into the information contained in neural signals, we hope to provide academic and practical innovations for the development of personalized treatment approaches for OCD.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• Diagnosed with OCD according to the criteria in the DSM-5.

• Age between 18 and 65 years.

• Duration of illness of more than 3 years.

• Ineffectiveness of systematic treatment with three types of serotonin reuptake inhibitors (including clomipramine) and augmentation agents, with no improvement after continuous high-dose serotonin reuptake inhibitor treatment for more than 12 weeks, or the occurrence of severe adverse drug reactions during treatment.

• Ineffectiveness of CBT treatment or repeated refusal of CBT treatment.

• Y-BOCS total score of 25 or higher.

• Significant impairment in social functioning, such as inability to work or attend school, or a noticeable decline in personal life skills.

• No severe impairment in insight, and capable of signing informed consent and surgery consent forms.

Locations
Other Locations
China
The First People's hospital of Longquanyi District
NOT_YET_RECRUITING
Chengdu
West CHina Hospital,Sichuan University
RECRUITING
Chengdu
Zigong Fifth People's Hospital
RECRUITING
Zigong
Zigong Fourth People's Hospital
NOT_YET_RECRUITING
Zigong
Contact Information
Primary
Botao Xiong, M.D.
botao-x@foxmail.com
13927498309
Backup
wei wang
wcnsww@163.com
Time Frame
Start Date: 2024-08-03
Estimated Completion Date: 2026-12-03
Participants
Target number of participants: 16
Treatments
Experimental: deep brain stimulation
Sponsors
Leads: West China Hospital
Collaborators: Beijing Pins Medical Co., Ltd

This content was sourced from clinicaltrials.gov